Johnson & Johnson to offer four prescription medicines on TrumpRx website - Reuters
Johnson & Johnson to offer four prescription medicines on TrumpRx website Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxOaGtIbmpWRkJrNVh6bEg2TXlqOTVqY2pnU1FVWGFCNWVaeS1NN3dZbG5zM3RKM2RDWjVsNmRiZk50eWppT0E5VlZPdmNGN3JqVDFURTY5NWRwczdGajRRYi11Z1VBcEZ2UEtBYmlReGxOdl9HS1p5TTZtcnNGVVdLd0pVckV3SXpETHZIYTJzWE92WXZacE43Uk9EVVlZM1lVRDJyTVJyU0pYVmRxQ1BzcEhZaVFkQm9wNHpMLU5lMGRXc1VMZlZnZXNDRXpYUDg0ekpHN3c4M3o3Rzc1cUdCNHZTYVF1UXc?oc=5" target="_blank">Johnson & Johnson to offer four prescription medicines on TrumpRx website</a> <font color="#6f6f6f">Reuters</font>
Johnson & Johnson will start selling four of its medications on the Trump administration's TrumpRx website, including diabetes drugs Invokamet, Invokamet XR, Invokana, and blood thinner Xarelto.
Johnson & Johnson will officially start marketing four of its medications on the Trump administration's TrumpRx website, including metformin, Invokana, and Xarelto.
Johnson & Johnson will start marketing four of its medications on the Trump administration's TrumpRx website, including diabetes drugs Invokamet, Invokamet XR, Invokana, and blood thinner Xarelto.
Johnson & Johnson will officially start marketing four of its medications on the Trump administration's TrumpRx website, including metformin, Invokana, and Xarelto.
Johnson & Johnson will start selling four of its medications on the Trump administration's TrumpRx website, including diabetes drugs Invokamet, Invokamet XR, Invokana, and blood thinner Xarelto, as part of an agreement to reduce drug prices for Americans.
Similar Stories
Related coverage based on topic and tags
Boots has a new owner: Three ways it could affect you
The stalwart of Britain's High Street has been sold to a Canadian billionaire family. What will that mean for you?
October 9, 2026 at 11:01 PMReport highlights flaws in ADHD and autism care
There is a risk of people being over-diagnosed with ADHD and autism, an official review in England has found.
October 9, 2026 at 01:52 PMHumana surges after topping 2027 Medicare star ratings - Reuters
Humana surges after topping 2027 Medicare star ratings Reuters
October 9, 2026 at 01:33 PMMost Medicare Advantage drug plan enrollees in high-quality plans, US government says - Reuters
Most Medicare Advantage drug plan enrollees in high-quality plans, US government says Reuters
October 8, 2026 at 11:29 PMADHD and autism at risk of over-diagnosis, says government review
The review, which focuses on younger people, warned there was a risk society was moving from an era of under-diagnosis to over-diagnosis.
October 8, 2026 at 11:01 PMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PM